Peripheral Markers of Apoptosis in Parkinson's Disease: The Effect of Dopaminergic Drugs
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A bstract: In this study, we measured the lymphocyte levels of proteins involved in apoptosis regulation, such as Bcl‐2, the peripheral benzodiazepine receptor (PBR), caspase‐3, and Cu/Zn superoxide dismutase (Cu/Zn SOD), in patients with Parkinson's disease (PD), either untreated or under therapy with dopaminergic agents (l‐Dopa alone or l‐dopa + dopamine agonists) and in healthy volunteers. All PD groups showed increased activity of caspase‐3, compared to controls, particularly those under treatment only with l‐Dopa. In this latter group, the increase in caspase‐3 activity was also paralleled by an increase in the concentration of Cu/Zn SOD. In addition, patients taking l‐Dopa + dopamine agonists showed marked decrease in Bcl‐2 levels and increased PBR expression, which seems in keeping with the hypothesis that PBR may be functionally related to Bcl‐2. In conclusion, we found clear modifications in the levels of proteins involved in the control of apoptosis in lymphocytes of PD patients. These changes were disease related but also modulated by the pharmacological treatment, which confirms the potential role of apoptosis in PD pathogenesis and the modulatory influence of dopaminergic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pergolide protects SH-SY5Y cells against neurodegeneration induced by H2O2
Uberti, D., Piccioni, L., Colzi, A., Bravi, D., Canonico, P. L., & Memo, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01537-0 · Cited by 49
Cited by
Molecular mechanisms of cell death in neurological diseases
Moujalled, D., Strasser, A., & Liddell, J. R. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00814-y · Cited by 749
“Examination of brain tissue from PD patients revealed abnormally increased levels of active caspase-3 and BAX [52] as well as significant reductions in BCL-2, which correlated inversely with disease duration and severity [53].”
BackgroundThe Role of Innate and Adaptive Immunity in Parkinson's Disease
Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324
“with PD [111].”
Yazdani, S., Mariosa, D., Hammar, N., Andersson, J., Ingre, C., Walldius, G., & Fang, F. (2019) · Annals of Neurology · doi:10.1002/ana.25614 · Cited by 42
Metadata
- Authors
- BLANDINI, F., MANGIAGALLI, A., COSENTINO, M., MARINO, F., SAMUELE, A., RASINI, E., FANCELLU, R., MARTIGNONI, E., RIBOLDAZZI, G., CALANDRELLA, D., FRIGO, G. M., & NAPPI, G.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2003-12
- Volume
- 1010
- Issue
- 1
- Pages
- 675-678
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1483752578
- Cited by
- 42
- References
- 1
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral Markers of Apoptosis in Parkinson's Disease: The Effect of Dopaminergic Drugs. https://app.cochat.ai/papers/10.1196/annals.1299.123
- The paper
- BLANDINI, F., MANGIAGALLI, A., COSENTINO, M., MARINO, F., SAMUELE, A., RASINI, E., FANCELLU, R., MARTIGNONI, E., RIBOLDAZZI, G., CALANDRELLA, D., FRIGO, G. M., & NAPPI, G. (2003). Peripheral Markers of Apoptosis in Parkinson's Disease: The Effect of Dopaminergic Drugs. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1299.123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.